Although vitiligo has no permanent cure, there are various latest treatments that can help manage the symptoms. Few advancements include,
Ruxolitinib Cream:
Each study looked at the efficacy and safety of a topical formulation of ruxolitinib in 300 individuals aged 12 and up who had nonsegmental vitiligo and depigmented areas. For 24 weeks, patients were randomly randomized to receive ruxolitinib 1.5 per cent cream twice daily or vehicle.
According to the findings of both studies, 29.9% of patients treated with ruxolitinib improved by at least 75% from baseline in their facial vitiligo.
This recent advancement has paved the way in the treatment of vitiligo.
